Yanhong Guo

1.3k total citations
30 papers, 684 citations indexed

About

Yanhong Guo is a scholar working on Molecular Biology, Physiology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Yanhong Guo has authored 30 papers receiving a total of 684 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 9 papers in Physiology and 6 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Yanhong Guo's work include Adipose Tissue and Metabolism (4 papers), Cardiovascular Disease and Adiposity (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Yanhong Guo is often cited by papers focused on Adipose Tissue and Metabolism (4 papers), Cardiovascular Disease and Adiposity (3 papers) and Renal Diseases and Glomerulopathies (3 papers). Yanhong Guo collaborates with scholars based in China, United States and Israel. Yanhong Guo's co-authors include Jifeng Zhang, Yanbo Fan, Minerva T. Garcia-Barrio, Y. Eugene Chen, Haocheng Lu, Ji Zhang, Wenying Liang, Lin Chang, Wei Gao and Luis Villacorta and has published in prestigious journals such as Journal of Clinical Investigation, PLoS ONE and Circulation Research.

In The Last Decade

Yanhong Guo

30 papers receiving 676 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Yanhong Guo China 15 306 142 104 98 93 30 684
Seong Jin Lee South Korea 18 290 0.9× 117 0.8× 119 1.1× 55 0.6× 204 2.2× 77 978
Michael Tranter United States 15 347 1.1× 209 1.5× 70 0.7× 106 1.1× 79 0.8× 34 740
Angela Serena Maione Italy 17 382 1.2× 327 2.3× 74 0.7× 95 1.0× 79 0.8× 45 854
Huihua Chen China 14 303 1.0× 170 1.2× 69 0.7× 72 0.7× 50 0.5× 54 663
Ruibing Li China 10 431 1.4× 84 0.6× 234 2.3× 67 0.7× 43 0.5× 23 744
Iwona Wybrańska Poland 15 327 1.1× 113 0.8× 80 0.8× 190 1.9× 102 1.1× 44 739
Xiaozhen Zhuo China 16 334 1.1× 130 0.9× 122 1.2× 138 1.4× 79 0.8× 30 733
Guowei Zhou China 15 226 0.7× 34 0.2× 52 0.5× 62 0.6× 72 0.8× 44 620
Emma Assi Italy 16 352 1.2× 45 0.3× 140 1.3× 127 1.3× 147 1.6× 25 873

Countries citing papers authored by Yanhong Guo

Since Specialization
Citations

This map shows the geographic impact of Yanhong Guo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yanhong Guo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yanhong Guo more than expected).

Fields of papers citing papers by Yanhong Guo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yanhong Guo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yanhong Guo. The network helps show where Yanhong Guo may publish in the future.

Co-authorship network of co-authors of Yanhong Guo

This figure shows the co-authorship network connecting the top 25 collaborators of Yanhong Guo. A scholar is included among the top collaborators of Yanhong Guo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yanhong Guo. Yanhong Guo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Wang, Zhenguo, Juan Zhong, Wenhao Xiong, et al.. (2025). Perivascular adipose tissue dysfunction contributes to thoracic aortic aneurysm development. Cardiovascular Diabetology. 24(1). 223–223. 3 indexed citations
2.
Li, Xiaodan, et al.. (2024). Efficacy and safety of rituximab in patients with PLA2R associated membranous nephropathy and resolved HCV infection. Scientific Reports. 14(1). 20981–20981. 1 indexed citations
3.
4.
Guo, Yanhong, et al.. (2023). Effect of rituximab in patients with PLA2R-associated membranous nephropathy and malignancy. International Immunopharmacology. 126. 111327–111327. 2 indexed citations
5.
Zhang, Chenghui, et al.. (2023). Baseline Serum BCAAs are Related to the Improvement in Insulin Resistance in Obese People After a Weight Loss Intervention. Diabetes Metabolic Syndrome and Obesity. Volume 16. 179–186. 6 indexed citations
6.
7.
Guo, Yanhong, Tingting Wang, Yulin Wang, et al.. (2022). Effects of sacubitril/valsartan in ESRD patients undergoing hemodialysis with HFpEF. Frontiers in Cardiovascular Medicine. 9. 955780–955780. 7 indexed citations
8.
Wang, Zhenguo, Haocheng Lu, Minerva T. Garcia-Barrio, et al.. (2022). RNA sequencing reveals perivascular adipose tissue plasticity in response to angiotensin II. Pharmacological Research. 178. 106183–106183. 23 indexed citations
9.
Gao, Xiaoming, et al.. (2022). N, S co-doped graphene quantum dots promote charge separation of Bi4O5BrxI2−x solid solution and enhance visible light photocatalytic performance. Colloids and Surfaces A Physicochemical and Engineering Aspects. 648. 129155–129155. 7 indexed citations
10.
Guo, Yanhong, Liuwei Wang, Yulin Wang, et al.. (2022). Rituximab in patients with membranous nephropathy and kidney insufficiency. Frontiers in Pharmacology. 13. 1002117–1002117. 6 indexed citations
11.
Guo, Yanhong, Pu Tian, Xiaodan Li, et al.. (2021). Relation of Serum Hepcidin Levels and Restless Legs Syndrome in Patients Undergoing Peritoneal Dialysis. Frontiers in Medicine. 8. 685601–685601. 3 indexed citations
12.
Wang, Qin, Jing Li, Chunyan Lu, et al.. (2021). Poor Status of Vitamin D: A Survey of Area With Lowest Sunlight Radiation in Sichuan, China. Frontiers in Endocrinology. 12. 626983–626983. 10 indexed citations
13.
Guo, Yanhong, Liuwei Wang, Rong Gou, et al.. (2020). SIRT1-modified human umbilical cord mesenchymal stem cells ameliorate experimental peritoneal fibrosis by inhibiting the TGF-β/Smad3 pathway. Stem Cell Research & Therapy. 11(1). 362–362. 14 indexed citations
14.
Guo, Yanhong, Liuwei Wang, Rong Gou, Lin Tang, & Peipei Liu. (2020). Noncoding RNAs in peritoneal fibrosis: Background, Mechanism, and Therapeutic Approach. Biomedicine & Pharmacotherapy. 129. 110385–110385. 14 indexed citations
15.
Rom, Oren, Guan Xu, Yanhong Guo, et al.. (2019). Nitro-fatty acids protect against steatosis and fibrosis during development of nonalcoholic fatty liver disease in mice. EBioMedicine. 41. 62–72. 40 indexed citations
16.
Mathew, Anna V., Lei Li, Jaeman Byun, et al.. (2018). Therapeutic Lifestyle Changes Improve HDL Function by Inhibiting Myeloperoxidase-Mediated Oxidation in Patients With Metabolic Syndrome. Diabetes Care. 41(11). 2431–2437. 29 indexed citations
17.
Hu, Wenting, Haocheng Lu, Jifeng Zhang, et al.. (2018). Krüppel-like factor 14, a coronary artery disease associated transcription factor, inhibits endothelial inflammation via NF-κB signaling pathway. Atherosclerosis. 278. 39–48. 29 indexed citations
18.
Zheng, Tao, et al.. (2018). Synthesis and crystal structure of a novel polymeric silver(I) complex. Molecular Crystals and Liquid Crystals. 666(1). 94–99. 1 indexed citations
19.
Zhang, Ji, Ji Zhang, Congzhen Qiao, et al.. (2016). Cardiomyocyte Overexpression of FABP4 Aggravates Pressure Overload-Induced Heart Hypertrophy. PLoS ONE. 11(6). e0157372–e0157372. 35 indexed citations
20.
Guo, Yanhong, Fengying Chen, Guisong Wang, Li Chen, & Wei Gao. (2008). Diet-induced hyperhomocysteinemia exacerbates vascular reverse remodeling of balloon-injured arteries in rat. Chinese Medical Journal. 121(22). 2265–2271. 16 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Seong Jin Lee Breakdown of academic impact, for papers by Michael Tranter Breakdown of academic impact, for papers by Angela Serena Maione Breakdown of academic impact, for papers by Huihua Chen Breakdown of academic impact, for papers by Ruibing Li Breakdown of academic impact, for papers by Iwona Wybrańska Breakdown of academic impact, for papers by Xiaozhen Zhuo Breakdown of academic impact, for papers by Guowei Zhou Breakdown of academic impact, for papers by Emma Assi
Rankless by CCL
2026